3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 25 0 1 0 0 0 0 0999 V2000
-1.3811 -2.1875 0.9503 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6809 1.6871 0.0282 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.7401 -0.3194 0.7236 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4424 0.6278 0.5383 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9709 -0.5320 -0.7828 C 0 0 1 0 0 0 0 0 0 0 0 0
-1.7679 0.7389 -1.1075 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4474 -0.2281 -0.4365 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6961 -1.1461 0.3921 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8501 0.7956 -0.0662 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4836 -0.8155 -1.1624 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7379 0.6434 0.6132 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8103 -0.5315 -0.8385 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0647 0.9274 0.9370 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1008 0.3399 0.2112 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0371 -1.2316 -1.6250 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.2454 0.6467 -2.0895 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.1829 1.6634 -1.0927 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.3704 -0.5121 1.4943 H 0 0 0 0 0 0 0 0 0 0 0 0
1.2730 -1.4964 -1.9827 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.0513 1.1116 1.1950 H 0 0 0 0 0 0 0 0 0 0 0 0
3.6089 -0.9955 -1.4116 H 0 0 0 0 0 0 0 0 0 0 0 0
2.2783 1.6077 1.7574 H 0 0 0 0 0 0 0 0 0 0 0 0
4.6534 1.2588 1.3000 H 0 0 0 0 0 0 0 0 0 0 0 0
5.1941 0.2012 0.0132 H 0 0 0 0 0 0 0 0 0 0 0 0
1 8 2 0 0 0 0
2 9 2 0 0 0 0
3 8 1 0 0 0 0
3 9 1 0 0 0 0
3 18 1 0 0 0 0
4 14 1 0 0 0 0
4 23 1 0 0 0 0
4 24 1 0 0 0 0
5 6 1 0 0 0 0
5 7 1 0 0 0 0
5 8 1 0 0 0 0
5 15 1 0 0 0 0
6 9 1 0 0 0 0
6 16 1 0 0 0 0
6 17 1 0 0 0 0
7 10 2 0 0 0 0
7 11 1 0 0 0 0
10 12 1 0 0 0 0
10 19 1 0 0 0 0
11 13 2 0 0 0 0
11 20 1 0 0 0 0
12 14 2 0 0 0 0
12 21 1 0 0 0 0
13 14 1 0 0 0 0
13 22 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
3-(4-aminophenyl)pyrrolidine-2,5-dione
4.2 InChl
InChI=1S/C10H10N2O2/c11-7-3-1-6(2-4-7)8-5-9(13)12-10(8)14/h1-4,8H,5,11H2,(H,12,13,14)
4.3 InChlKey
AFLGSUFOCCZEEZ-UHFFFAOYSA-N
4.4 Canonical SMILES
C1C(C(=O)NC1=O)C2=CC=C(C=C2)N
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病